Thrombospondins: from structure to therapeutics
- 12 January 2008
- journal article
- review article
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 65 (5) , 728-742
- https://doi.org/10.1007/s00018-007-7488-x
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- Endogenous thrombospondin-1 is not necessary for proliferation but is permissive for vascular smooth muscle cell responses to platelet-derived growth factorMatrix Biology, 2005
- The N-terminus of thrombospondin: the domain stands apartThe International Journal of Biochemistry & Cell Biology, 2004
- Recognition of the N-terminal Modules of Thrombospondin-1 and Thrombospondin-2 by α6β1 IntegrinJournal of Biological Chemistry, 2003
- Interactions of thrombospondins with α4β1 integrin and CD47 differentially modulate T cell behaviorThe Journal of cell biology, 2002
- N-terminal N -myristoylation of proteins: prediction of substrate proteins from amino acid sequence 1 1Edited by J. ThorntonJournal of Molecular Biology, 2002
- CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolismJournal of Clinical Investigation, 2001
- Integrin-associated protein (CD47) and its ligandsTrends in Cell Biology, 2001
- Cooperation between Thrombospondin-1 Type 1 Repeat Peptides and αvβ3 Integrin Ligands to Promote Melanoma Cell Spreading and Focal Adhesion Kinase PhosphorylationJournal of Biological Chemistry, 1999
- Nitric oxide. A novel signal transduction mechanism for transcellular communication.Hypertension, 1990
- Specific inhibition of endothelial cell proliferation by thrombospondinBiochemical and Biophysical Research Communications, 1990